Research Topics
| Jennifer S SmithSummaryAffiliation: International Agency for Research on Cancer Country: France Publications
| Collaborators
|
Detail Information
Publications
Prevalence and risk factors for herpes simplex virus type 2 infection among middle-age women in Brazil and the PhilippinesJ S Smith
International Agency for Research on Cancer, Lyon, France
Sex Transm Dis 28:187-94. 2001..Data comparing type-specific herpes simplex virus type 2 (HSV-2) seroprevalence and risk factors between comparable populations are largely unavailable, particularly from less-developed countries...- Herpes simplex virus-2 as a human papillomavirus cofactor in the etiology of invasive cervical cancerJennifer S Smith
Unit of Field and Intervention Studies, International Agency for Research on Cancer IARC, Lyon, France
J Natl Cancer Inst 94:1604-13. 2002..We performed a pooled analysis of seven case-control studies to examine the effect of one possible HPV cofactor, herpes simplex virus-2 (HSV-2) infection, in the etiology of invasive cervical cancer... - Age-specific prevalence of infection with herpes simplex virus types 2 and 1: a global reviewJennifer S Smith
International Agency for Research on Cancer IARC, Unit of Field and Intervention Studies, 69372 Lyon, France
J Infect Dis 186:S3-28. 2002..HSV-1 infection is acquired during childhood and adolescence and is markedly more widespread than HSV-2 infection. Further studies are needed in many geographic areas... - Evidence for Chlamydia trachomatis as a human papillomavirus cofactor in the etiology of invasive cervical cancer in Brazil and the PhilippinesJennifer S Smith
International Agency for Research on Cancer, F 69372 Lyon Cedex 08, France
J Infect Dis 185:324-31. 2002..C. trachomatis infection was found to be a possible cofactor of HPV in the etiology of squamous cervical cancer, and its effect may be mediated by chronic inflammation... - Adeno-associated virus seropositivity and HPV-induced cervical cancer in Spain and ColombiaJ Smith
International Agency for Research on Cancer, Lyon, France
Int J Cancer 94:520-6. 2001.... - Chlamydia trachomatis and invasive cervical cancer: a pooled analysis of the IARC multicentric case-control studyJennifer S Smith
International Agency for Research on Cancer, Lyon, France
Int J Cancer 111:431-9. 2004..0; 95% CI = 0.53-1.9) in HPV DNA-positive women. An association of C. trachomatis with squamous cell ICC was found among all cases and control women with or without adjustment for HPV... - Sexual behavior, condom use, and human papillomavirus: pooled analysis of the IARC human papillomavirus prevalence surveysSalvatore Vaccarella
International Agency for Research on Cancer, 150 cours Albert Thomas, 69372 Lyon Cedex 08, France
Cancer Epidemiol Biomarkers Prev 15:326-33. 2006..Our study showed an effect of both women's and their husbands' sexual behavior on HPV positivity. Furthermore, it suggests some differences in the pattern of the association between sexual behavior and different HPV types... - Role of parity and human papillomavirus in cervical cancer: the IARC multicentric case-control studyNubia Munoz
Unit of Field and Intervention Studies, International Agency for Research on Cancer, 150 cours Albert Thomas, F 69372, Cedex 08, Lyon, France
Lancet 359:1093-101. 2002..To assess the role of reproductive factors in the progression from HPV infection to cancer, we did a pooled analysis including only HPV-positive women... - Cervical infection with Chlamydia trachomatis and Neisseria gonorrhoeae in women from ten areas in four continents. A cross-sectional studySilvia Franceschi
International Agency for Research on Cancer, Lyon, France
Sex Transm Dis 34:563-9. 2007..Better information on the prevalence of Chlamydia trachomatis (CT) and Neisseria gonorrhoeae (NG) infection is needed in many world areas... - Human papillomavirus genotype distribution in low-grade cervical lesions: comparison by geographic region and with cervical cancerGary M Clifford
IARC, 150 cours Albert Thomas, F 69372 Lyon Cedex 08, France
Cancer Epidemiol Biomarkers Prev 14:1157-64. 2005..Some regional differences in the relative importance of HPV genotypes in LSIL were noted... 
HIV, human papillomavirus, and cervical neoplasia and cancer in the era of highly active antiretroviral therapyHugo De Vuyst
Department of Obstetrics and Gynaecology, Ghent University, Belgium
Eur J Cancer Prev 17:545-54. 2008..Therefore, it remains important to closely monitor HPV-related disease in women with HIV who are receiving HAART, particularly in regions of the world where cervical screening is not available routinely...- Cervical cancer and use of hormonal contraceptives: a systematic reviewJennifer S Smith
International Agency for Research on Cancer, Lyon, France
Lancet 361:1159-67. 2003.... 
Persistent human papillomavirus infection and cervical neoplasia: a systematic review and meta-analysisJill Koshiol
Cancer Prevention Fellowship Program, Division of Cancer Prevention, National Cancer Institute, Bethesda, MD 20892 7236, USA
Am J Epidemiol 168:123-37. 2008..Precise definition and standardization of HPV testing, sampling procedure, and test interval are needed for reliable clinical testing. These findings validate HPV persistence as a clinical marker and endpoint...- Age-specific prevalence of infection with human papillomavirus in females: a global reviewJennifer S Smith
Department of Epidemiology, University of North Carolina, Chapel Hill, North Carolina 27599, USA
J Adolesc Health 43:S5-25, S25.e1-41. 2008..Global data on age-specific prevalence of human papillomavirus (HPV) infection overall, and for high-risk HPV types 16 and 18, are essential for the future implementation of HPV prophylactic vaccines for cervical cancer prevention... - Smoking and time to clearance of human papillomavirus infection in HIV-seropositive and HIV-seronegative womenJill Koshiol
Department of Epidemiology, School of Public Health, University of North Carolina at Chapel Hill, USA
Am J Epidemiol 164:176-83. 2006..93, 95% CI: 0.68, 1.26) women. HPV clearance did not appear to vary by amount or duration of smoking. Smoking did not modify overall clearance but was associated with lower high-risk HPV clearance in HIV-seronegative women... - [The prevalence of high-risk HPV infection in pregnant women from Morelos, México]Carlos Hernández-Girón
Centro de Investigaciones en Salud Poblacional, Instituto Nacional de Salud Publica, Cuernavaca, Morelos, Mexico
Salud Publica Mex 47:423-9. 2005..This association, however, has not been firmly established. This study seeks to determine the prevalence of oncogenic HPV infecton in a sample of pregnant Mexican women and its possible risk factors... - Descriptive evidence that risk profiles for cervical intraepithelial neoplasia 1, 2, and 3 are uniqueSuzanne Belinson
Department of Preventive Medicine, Northwestern University, Chicago, IL 60622, USA
Cancer Epidemiol Biomarkers Prev 17:2350-5. 2008..This study aimed to estimate if risk factor profiles for histologically confirmed cervical intraepithelial neoplasia (CIN) 2 lesions differ from those for CIN 1 or 3... - Human papillomavirus type distribution in invasive cervical cancer and high-grade cervical lesions: a meta-analysis updateJennifer S Smith
Department of Epidemiology, University of North Carolina Chapel Hill, Chapel Hill, NC 27599 7435, USA
Int J Cancer 121:621-32. 2007..Data on HPV-typed ICC and HSIL cases were particularly scarce from large regions of Africa and Central Asia... - Lack of association between serum antibodies of Chlamydia pneumoniae infection and the risk of lung cancerJennifer S Smith
Int J Cancer 123:2469-71. 2008 - Human papillomavirus detection by penile site in young men from KenyaJennifer S Smith
Department of Epidemiology, University of North Carolina, Chapel Hill, NC, USA
Sex Transm Dis 34:928-34. 2007..Limited data are available on whether sampling from the penile shaft or urethra increases detection of penile HPV infection in men beyond that found in the glans and coronal sulcus... - Type-specific seroprevalence of herpes simplex virus type 2 and associated risk factors in middle-aged women from 6 countries: the IARC multicentric studyPadmaja Patnaik
Department of Epidemiology, CB 7435, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599 7435, USA
Sex Transm Dis 34:1019-24. 2007..To determine type-specific seroprevalence of herpes simplex viruses (HSV-1 and HSV-2) and HSV-2 risk factors... - Herpes simplex virus 2 infection in women attending an antenatal clinic in Fuzhou, ChinaXiang Sheng Chen
National Center for STD Control, Nanjing, China
Sex Transm Infect 83:369-70. 2007..Consequently, we conducted a survey to determine type specific seroprevalence of HSV-2 and associated risk factors in Fuzhou City, eastern China... - Worldwide human papillomavirus etiology of cervical adenocarcinoma and its cofactors: implications for screening and preventionXavier Castellsague
Institut d Investigacio Biomedica de Bellvitge, Cancer Epidemiology and Registration Unit, Institut Català d Oncologia L Hospitalet de Llobregat, Barcelona, Spain
J Natl Cancer Inst 98:303-15. 2006..The extent to which human papillomavirus (HPV) infection and cofactors may explain this differential trend is unclear... - [Seroprevalence of type 2 herpes simplex virus infection in 3 population groups of Mexico City]Carlos J Conde-Gonzalez
Dirección de Microbiología, Centro De Investigacion sobre Enfermedades Infecciosas, Instituto Nacional de Salud Publica, Avenida Universidad 655, Colonia Santa Maria Ahuacatitlan, 62508 Cuernavaca, Morelos, Mexico
Salud Publica Mex 45:S608-16. 2003..To determine the seroprevalence of type 2 herpes simplex virus (HSV-2) infection and risk factors in three female population groups in Mexico City... - Prevalence of human papillomavirus infection in women in Busan, South KoreaHai-Rim Shin
Division of Cancer Epidemiology and Control, National Cancer Center Research Institute, Goyang, Korea
Int J Cancer 103:413-21. 2003..Among 103 virgins, 4.9% had anti-VLPs (1/73 among those aged 24 years or less)... - Male circumcision, penile human papillomavirus infection, and cervical cancer in female partnersXavier Castellsague
Servei d Epidemiologia i Registre del Cancer, Institut Catala d Oncologia, Hospitalet de Llobregat, Barcelona, Spain
N Engl J Med 346:1105-12. 2002..It is uncertain whether male circumcision reduces the risks of penile human papillomavirus (HPV) infection in the man and of cervical cancer in his female partner... - Population-based human papillomavirus prevalence in Lampang and Songkla, ThailandSukhon Sukvirach
Research Division, National Cancer Institute, Bangkok, Thailand
J Infect Dis 187:1246-56. 2003..2%) than among women from Songkla (10.9%). Major risk factors for cervical HPV DNA were age <35 years, HSV-2 seropositivity, and having a husband with extramarital sexual partners... - Chlamydia trachomatis and Human papillomavirus infections in cervical disease in Argentine womenCarlos D Golijow
Centro de Investigaciones en Genética Básica y Aplicada CIGEBA, Facultad de Ciencias Veterinarias, UNLP Calle 60 y 118 s n, B1900AVW, La Plata, Argentina
Gynecol Oncol 96:181-6. 2005..To examine the prevalence of Human papillomavirus and Chlamydia trachomatis DNA in cervical samples among women with normal and abnormal cervical cytology from La Plata, Argentina... - Human papillomavirus DNA detection and typing in male urine samples from a high-risk population from ArgentinaCarlos D Golijow
Centro de Investigaciones en Genética Básica y Aplicada CIGEBA, Facultad de Ciencias Veterinarias, Universidad Nacional de La Plata, Calle 60 y 118 S N, B1900AVW, La Plata, Argentina
J Virol Methods 124:217-20. 2005..The method described below provides a tool for detection and typing of HPV-DNA using samples obtained by non-invasive techniques and thus easy to obtain... - Chlamydia trachomatis infection in female partners of circumcised and uncircumcised adult menXavier Castellsague
Cancer Epidemiology and Registration Unit, Institut d Investigacio Biomedica de Bellvitge, Institut Catala d Oncologia, L Hospitalet de Llobregat, Barcelona, Spain
Am J Epidemiol 162:907-16. 2005..These findings suggest that male circumcision could reduce the risk of C. trachomatis infection in female sexual partners... - High-risk human papillomavirus detection and related risk factors among pregnant and nonpregnant women in MexicoCarlos Hernández-Girón
Centro de Investigaciones en Salud Poblacional, INSP, Cuernavaca, Mexico
Sex Transm Dis 32:613-8. 2005..We also investigated the relationship of HPV DNA positivity with socioeconomic, gynecologic, and obstetric risk factors... - Human papillomavirus infection among women in South and North VietnamThi Hoang Anh Pham
, National Cancer Institute, Hanoi, Vietnam
Int J Cancer 104:213-20. 2003..Women in Hanoi showed the lowest HPV prevalence ever reported so far, suggesting that HPV has not spread widely in this population. As expected, HPV prevalence in a population seemed to be closely correlated with ICC incidence rates... - Bacterial vaginosis and HIV acquisition: a meta-analysis of published studiesJulius Atashili
Department of Epidemiology, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina 27599 7435, USA
AIDS 22:1493-501. 2008..To assess and summarize the published literature on the extent to which bacterial vaginosis may increase the risk of HIV acquisition... - Issues in human papillomavirus vaccination in adolescentsAnna-Barbara Moscicki
J Adolesc Health 43:S1-4. 2008 - Potential barriers to HPV vaccine provision among medical practices in an area with high rates of cervical cancerKatie M Keating
School of Public Health, University of North Carolina, Chapel Hill, North Carolina 27516, USA
J Adolesc Health 43:S61-7. 2008..We provide an overview of potential barriers to provision of HPV vaccine and empirical data on the concerns of medical practices that may inhibit HPV vaccine provision... - Age considerations when vaccinating against HPVThomas C Wright
Columbia University, New York, New York 10032, USA
Gynecol Oncol 109:S40-7. 2008..This review discusses the various considerations that should be addressed when making recommendations of who should be vaccinated against HPV... - Initial lessons learned in HPV vaccinationThomas J Herzog
Columbia University, College of Physicians and Surgeons, Department of Obstetrics and Gynecology, 161 Fort Washington Avenue, 8th Floor New York, NY 10032, USA
Gynecol Oncol 109:S4-11. 2008..This article also examines the impact of the HPV vaccination awareness campaign on media and public policy dynamics... - Effect of topically applied resveratrol on cutaneous herpes simplex virus infections in hairless miceJohn J Docherty
Department of Microbiology Immunology, Northeastern Ohio Universities, College of Medicine, PO Box 95, State Route 44, Rootstown, OH 44272, USA
Antiviral Res 61:19-26. 2004..These studies demonstrate that topically applied resveratrol inhibits HSV lesion formation in the skin of mice... - The disparity of cervical cancer in diverse populationsLevi S Downs
University of Minnesota, Dept of OB GYN and Women s Health, 420 Delaware Street, 8395 SE, MMC 395 Mayo, Minneapolis, MN 55455, USA
Gynecol Oncol 109:S22-30. 2008..Strategies to reduce cervical cancer disparities need to be employed in order to reverse these trends... - HPV vaccine acceptability in a rural Southern areaKarah I Fazekas
School of Public Health, University of North Carolina, Chapel Hill, North Carolina 27599, USA
J Womens Health (Larchmt) 17:539-48. 2008..Although cervical cancer rates in the United States are highest in Southern and rural areas, research on human papillomavirus (HPV) vaccine acceptability has focused on other geographic areas... - Influence of parent characteristics and disease outcome framing on HPV vaccine acceptability among rural, Southern womenNina R Sperber
School of Public Health, Department of Health Behavior and Health Education, University of North Carolina, Chapel Hill, NC 27599 7400, USA
Cancer Causes Control 19:115-8. 2008..This study explored the impact of framing the vaccine's benefits, with respect to the disease outcome being prevented, on women's HPV vaccination intentions for themselves and for an adolescent daughter... - Correlates of national HIV seroprevalence: an ecologic analysis of 122 developing countriesPaul K Drain
School of Medicine, University of Washington, Seattle, WA, USA
J Acquir Immune Defic Syndr 35:407-20. 2004..Correlations with selected health indicators suggest additional obstacles for implementing HIV treatment programs... - Factors underlying disparities in cervical cancer incidence, screening, and treatment in the United StatesAletha Y Akers
Robert Wood Johnson Clinical Scholars Program, University of North Carolina, Chapel Hill, North Carolina, USA
Curr Probl Cancer 31:157-81. 2007 - Time to clearance of human papillomavirus infection by type and human immunodeficiency virus serostatusJill E Koshiol
Department of Epidemiology, University of North Carolina, Chapel Hill, NC, USA
Int J Cancer 119:1623-9. 2006..57 (95% CI: 0.22-1.45) for HIV-positive and -negative women, respectively. HPV types within the high-risk category had low estimated clearance rates relative to low-risk types, but HRs were not substantially modified by HIV serostatus... - The current and future role of screening in the era of HPV vaccinationEvan Myers
Division of Clinical and Epidemiological Research, Department of Obstetrics and Gynecology, DUMC 3279, 244 Baker House, Duke University Medical Center, Durham, NC 27710, USA
Gynecol Oncol 109:S31-9. 2008....